Therese Fagerqvist

Immunotherapy targeting α-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] α-synuclein mice

Veronica Lindström, Therese Fagerqvist, Eva Nordström et al. · Neurobiology of Disease · 2014 · 134 citations · Full text

Life Sciences, Neurobiology, Neuroscience +7

The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of α-synuclein oligomers with distinct biochemical, morphological, and functional properties

Thomas Näsström, Therese Fagerqvist, Mikael Barbu et al. · Free Radical Biology and Medicine · 2010 · 132 citations

Life Sciences, Biochemistry, Lipid Biochemistry +16

Monoclonal antibodies selective for α‐synuclein oligomers/protofibrils recognize brain pathology in Lewy body disorders and α‐synuclein transgenic mice with the disease‐causing A30P mutation

Therese Fagerqvist, Veronica Lindström, Eva Nordström et al. · Journal of Neurochemistry · 2013 · 86 citations

Life Sciences, Neurology, Neuroscience +14

Off-pathway<b>α</b>-synuclein oligomers seem to alter<b>α</b>-synuclein turnover in a cell model but lack seeding capability<i>in vivo</i>

Therese Fagerqvist, Thomas Näsström, Elisabet Ihse et al. · Amyloid · 2013 · 26 citations

Life Sciences, Neurobiology, Neuroscience +17

Building a precision medicine infrastructure at a national level: The Swedish experience

Anders Edsjö, Anna Lindstrand, David Gisselsson et al. · Cambridge Prisms Precision Medicine · 2023 · 20 citations · Full text

Medicine, Biomedical Informatics, Health Informatics +13